preview

Obamacare : Promise For Antibiotics And Therapeutics For Health Act Or The Path Act Essay

Better Essays

Healthcare Legislation Project: S.185: Promise for Antibiotics and Therapeutics for Health Act or the PATH Act Introduction: The Promise for Antibiotics and Therapeutics for Health Act or the PATH Act was introduced to the 114th Congress (2015 – 2016) by sponsor Senator Orrin Hatch, R-Utah with the support of Senator(s) Michael Bennett (D-Colorado), Kelly Ayottee (R-New Hampshire), John Isakson (R-Georgia), Mark Kirk (R-Illinois), Tom Carper (D-Delaware), and Richard Blumenthal (D-Connecticut) on January 16th, 2015. This legislation is currently being reviewed by the Senate Committee on Health, Education, Labor and Pension. After which, it will be come up for vote in both the Senate and House, before being presented to the President for approval into law. Section 3 of the Promise for Antibiotics and Therapeutics for Health Act or the PATH Act, which call for current PATH Act legislation to be modified so that it “will allow health experts to more easily develop new treatments for antibiotic resistant bacteria, and make real progress in presenting a great number of illnesses and deaths in the United States”1. In addition, this new legislation will impact Section 506 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C 356) by introducing into its current language a new subsection (g) “Limited Population Pathway for Antibacterial Drugs”. Thus creating new avenues for the introduction of alternative treatments for limited populations based on the recommendation of Secretary

Get Access